Chronic Immune Stimulation Correlates with Reduced Phenylalanine Turnover
The DOI matches its Crossref record.
Abstract
Neuropsychiatric symptoms like mood changes and depression are common in patients with chronic inflammatory disorders such as infections, autoimmune diseases or cancer. The pathogenesis of these symptoms is still unclear. Pro-inflammatory stimuli interfere not only with the neural circuits and neurotransmitters of the serotonergic, but also with those of the adrenergic system. The pro-inflammatory cytokine interferon-gamma stimulates the biosynthesis of 5,6,7,8-tetrahydrobiopterin (BH4), which is cofactor for several aromatic amino acid monooxygenases and thus is strongly involved in the biosynthesis of the neurotransmitter serotonin and the catecholamines dopamine, epinephrine (adrenaline) and norepinephrine (noradrenaline). In macrophages, interferon-gamma also triggers the high output of reactive oxygen species, which can destroy the oxidation-labile BH4. Recent data suggest that oxidative loss of BH4 in chronic inflammatory conditions can reduce the biosynthesis of catecholamines, which may relate to disturbed adrenergic neurotransmitter pathways in patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Through the generation of reactive oxygen and nitrogen species, inflammatory cytokines have also been found to decrease the availability of tetrahydrobiopterin (BH4), a key enzyme co-factor in the synthesis of all monoamines that is highly sensitive to oxidative stress73.”
From The role of inflammation in depression: from evolutionary imperative to modern treatment target (2016) · cites this paper as [73]
Citations
Cites
Still being checked.
Cited by
The role of inflammation in depression: from evolutionary imperative to modern treatment target
Miller, A. H., & Raison, C. L. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2015.5 · Cited by 3,942
Raison, C. L., Rutherford, R. E., Woolwine, B. J., Shuo, C., Schettler, P., Drake, D. F., Haroon, E., & Miller, A. H. (2013) · JAMA Psychiatry · doi:10.1001/2013.jamapsychiatry.4 · Cited by 1,617
Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications
Felger, J. C., & Lotrich, F. E. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.04.060 · Cited by 1,180
Haroon, E., Raison, C. L., & Miller, A. H. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.205 · Cited by 1,000
“…BH4 also is a cofactor for phenylalanine-4-hydroxylase (PAH), which converts phenylalanine (phe) to tyrosine (tyr), investigators have used peripheral blood measures of phe, tyr, and/or the phe/tyr ratio as a measure of PAH activity and indirectly the availability of BH4 (Neurauter et al, 2008).”
BackgroundInfluentialMiller, A. H., Haroon, E., Raison, C. L., & Felger, J. C. (2013) · Depression and Anxiety · doi:10.1002/da.22084 · Cited by 892
“BH4 is very sensitive to oxidative stress that can lead to irreversible degradation of BH4 to dihydroxyanthopterin.[62]”
BackgroundPenninx, B. W., Milaneschi, Y., Lamers, F., & Vogelzangs, N. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-129 · Cited by 839
Calder, P. C., Bosco, N., Bourdet-Sicard, R., Capuron, L., Delzenne, N., Doré, J., Franceschi, C., Lehtinen, M. J., Recker, T., Salvioli, S., et al. (2017) · Ageing Research Reviews · doi:10.1016/j.arr.2017.09.001 · Cited by 488
Inflammation Effects on Motivation and Motor Activity: Role of Dopamine
Felger, J. C., & Treadway, M. T. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2016.143 · Cited by 442
Imaging the Role of Inflammation in Mood and Anxiety-related Disorders
Felger, J. C. (2018) · Current Neuropharmacology · doi:10.2174/1570159x15666171123201142 · Cited by 427
Felger, J. C., & Miller, A. H. (2012) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2012.09.003 · Cited by 391
Capuron, L., Pagnoni, G., Drake, D. F., Woolwine, B. J., Spivey, J. R., Crowe, R. J., Votaw, J. R., Goodman, M. M., & Miller, A. H. (2012) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.2094 · Cited by 382
“In addition, BH4 can be consumed in the context of inflammation-induced production of NO.(45) For example, intramuscular injection of interferon alfa to rats has been shown to decrease central nervous system concentrations of BH4 through stimulation of NO.”
BackgroundInfluentialCapuron, L., Schroecksnadel, S., Féart, C., Aubert, A., Higueret, D., Barberger-Gateau, P., Layé, S., & Fuchs, D. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.12.006 · Cited by 368
Self-citationThe neuroimmune basis of fatigue
Dantzer, R., Heijnen, C. J., Kavelaars, A., Laye, S., & Capuron, L. (2014) · Trends in Neurosciences · doi:10.1016/j.tins.2013.10.003 · Cited by 346
Oxenkrug, G. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8497-4 · Cited by 254
Loftis, J. M., Huckans, M., & Morasco, B. J. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.11.015 · Cited by 252
Hepatitis C infection, antiviral treatment and mental health: A European expert consensus statement
Schaefer, M., Capuron, L., Friebe, A., Diez-Quevedo, C., Robaeys, G., Neri, S., Foster, G. R., Kautz, A., Forton, D., & Pariante, C. M. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.07.037 · Cited by 225
Felger, J. C., Mun, J., Kimmel, H. L., Nye, J. A., Drake, D. F., Hernandez, C. R., Freeman, A. A., Rye, D. B., Goodman, M. M., Howell, L. L., et al. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.115 · Cited by 214
“However, sustained inflammation can increase both reactive oxygen species and inducible nitric oxide synthase activity that may ultimately lead to decreased BH4 availability and thus reduced DA synthesis (Felger and Miller, 2012; Neurauter et al, 2008).”
BackgroundResultAntidepressant therapies inhibit inflammation and microglial M1-polarization
Kalkman, H. O., & Feuerbach, D. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.04.001 · Cited by 212
Toxoplasma gondii‐induced neuronal alterations
Parlog, A., Schlüter, D., & Dunay, I. R. (2015) · Parasite Immunology · doi:10.1111/pim.12157 · Cited by 201
Modulatory effects of α7 nAChRs on the immune system and its relevance for CNS disorders
Kalkman, H. O., & Feuerbach, D. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2175-4 · Cited by 181
Dietary fiber and its associations with depression and inflammation
Swann, O. G., Kilpatrick, M., Breslin, M., & Oddy, W. H. (2020) · Nutrition Reviews · doi:10.1093/nutrit/nuz072 · Cited by 185
Felger, J. C., Li, L., Marvar, P. J., Woolwine, B. J., Harrison, D. G., Raison, C. L., & Miller, A. H. (2013) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2012.10.010 · Cited by 176
“Previous studies have reported similar group differences in Phen/Tyr ratio that have been associated with behavioral alterations and markers of inflammation and oxidative stress (Capuron et al. 2011; Neurauter et al. 2008a; Neurauter et al. 2008b; Zangerle et al. 2010).”
InfluentialThe role of depressive subtypes within the neuroinflammation hypothesis of major depressive disorder
Woelfer, M., Kasties, V., Kahlfuss, S., & Walter, M. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2018.03.034 · Cited by 171
Inflammation-Induced Tryptophan Breakdown is Related With Anemia, Fatigue, and Depression in Cancer
Lanser, L., Kink, P., Egger, E. M., Willenbacher, W., Fuchs, D., Weiss, G., & Kurz, K. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00249 · Cited by 169
Self-citationPoor cognitive ageing: Vulnerabilities, mechanisms and the impact of nutritional interventions
Miquel, S., Champ, C., Day, J., Aarts, E., Bahr, B. A., Bakker, M., Bánáti, D., Calabrese, V., Cederholm, T., Cryan, J., et al. (2018) · Ageing Research Reviews · doi:10.1016/j.arr.2017.12.004 · Cited by 162
Neopterin, a prognostic marker in human malignancies
Sucher, R., Schroecksnadel, K., Weiss, G., Margreiter, R., Fuchs, D., & Brandacher, G. (2010) · Cancer Letters · doi:10.1016/j.canlet.2009.05.008 · Cited by 161
Self-citationSerotonin – Kynurenine Hypothesis of Depression: Historical Overview and Recent Developments
Oxenkrug, G. (2013) · Current Drug Targets · doi:10.2174/1389450111314050002 · Cited by 160
Therapeutic Implications of Brain–Immune Interactions: Treatment in Translation
Miller, A. H., Haroon, E., & Felger, J. C. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2016.167 · Cited by 152
Exercise, inflammation, and fatigue in cancer survivors
LaVoy, E. C. P., Fagundes, C. P., & Dantzer, R. (2026) · PubMed · doi:10.22029/eir.2016.1710 · Cited by 138
Amino acids in the regulation of aging and aging-related diseases
Canfield, C.-A., & Bradshaw, P. C. (2019) · Translational Medicine of Aging · doi:10.1016/j.tma.2019.09.001 · Cited by 133
Immune changes and neurotransmitters: Possible interactions in depression?
Sperner‐Unterweger, B., Kohl, C. A., & Fuchs, D. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.10.006 · Cited by 146
Self-citationTetrahydrobioterin (BH4) pathway: from metabolism to neuropsychiatry
Fanet, H., Capuron, L., Castanon, N., Calon, F., & Vancassel, S. (2021) · Current Neuropharmacology · doi:10.2174/1570159x18666200729103529 · Cited by 134
Vogelzangs, N., Beekman, A. T., van Reedt Dortland, A. K., Schoevers, R. A., Giltay, E. J., de Jonge, P., & Penninx, B. W. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.9 · Cited by 133
“…effects on the monoamine system, such as increasing the activity of monoamine transporters (Zhu et al, 2006) and reducing the concentration of monoamine precursors (Widner et al, 2002) and monoamine biosynthesis (Neurauter et al, 2008), which counterbalance the effects of antidepressant medication.”
BackgroundMapping inflammation onto mood: inflammatory mediators of anhedonia
Swardfager, W., Rosenblat, J. D., Benlamri, M., & McIntyre, R. S. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.02.017 · Cited by 125
Depression and chronic liver diseases: are there shared underlying mechanisms?
Huang, X., Liu, X., & Yu, Y. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00134 · Cited by 121
“…significant alterations in serotonin, dopamine and norepinephrine neurotransmitter metabolism and activation of a pro-inflammatory cytokine network are involved in psychiatric disorders associated with IFN-α (Widner et al., 2000; Raison et al., 2005b; Neurauter et al., 2008; Capuron et al., 2011).”
BackgroundGoldsmith, D. R., & Rapaport, M. H. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00046 · Cited by 123
The role of dopamine in inflammation-associated depression: mechanisms and therapeutic implications
Felger, J. C. (2016) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2016_13 · Cited by 115
Elevated fecal calprotectin in patients with Alzheimer’s dementia indicates leaky gut
Leblhuber, F., Geisler, S., Steiner, K., Fuchs, D., & Schütz, B. (2015) · Journal of Neural Transmission · doi:10.1007/s00702-015-1381-9 · Cited by 119
Self-citationAthira, K. V., Bandopadhyay, S., Samudrala, P. K., Naidu, V. G. M., Lahkar, M., & Chakravarty, S. (2019) · Current Neuropharmacology · doi:10.2174/1570159x17666191001142934 · Cited by 119
The interplay of hypoxic and mental stress: Implications for anxiety and depressive disorders
Burtscher, J., Niedermeier, M., Hüfner, K., van den Burg, E. H., Kopp, M., Stoop, R., Burtscher, M., Gatterer, H., & Millet, G. P. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104718 · Cited by 136
Biological Markers in Anxiety Disorders
Łoś, K., & Waszkiewicz, N. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10081744 · Cited by 117
Murr, C., Grammer, T. B., Meinitzer, A., Kleber, M. E., März, W., & Fuchs, D. (2014) · Journal of Amino Acids · doi:10.1155/2014/783730 · Cited by 117
Self-citationPharmacological effects of berberine on mood disorders
Fan, J., Zhang, K., Jin, Y., Li, B., Gao, S., Zhu, J., & Cui, R. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13930 · Cited by 110
Effects of Exhaustive Aerobic Exercise on Tryptophan-Kynurenine Metabolism in Trained Athletes
Strasser, B., Geiger, D., Schauer, M., Gatterer, H., Burtscher, M., & Fuchs, D. (2016) · PLOS ONE · doi:10.1371/journal.pone.0153617 · Cited by 99
Self-citationStrasser, B., Sperner‐Unterweger, B., Fuchs, D., & Gostner, J. M. (2016) · Current topics in behavioral neurosciences · doi:10.1007/7854_2016_23 · Cited by 115
Self-citationVancassel, S., Capuron, L., & Castanon, N. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00499 · Cited by 94
Zangerle, R., Kurz, K., Neurauter, G., Kitchen, M., Sarcletti, M., & Fuchs, D. (2009) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2009.11.004 · Cited by 111
Self-citationWallace, C. W., & Fordahl, S. C. (2021) · Nutrition Research Reviews · doi:10.1017/s0954422421000196 · Cited by 107
Tayab, M. A., Islam, M. N., Chowdhury, K. A. A., & Tasnim, F. M. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112668 · Cited by 96
Han, B., Li, X., & Hao, J. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.04.002 · Cited by 108
Treatment-resistant depression: molecular mechanisms and management
Kajumba, M. M., Kakooza‐Mwesige, A., Nakasujja, N., Attix, D. K., & Canli, T. (2024) · Molecular Biomedicine · doi:10.1186/s43556-024-00205-y · Cited by 106
Štrac, D. Š., Pivac, N., Smolders, I. J., Fogel, W. A., Deurwaerdère, P. D., & Giovanni, G. D. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00492 · Cited by 106
Role of Inflammation in Depression and Treatment Implications
Felger, J. C. (2018) · Handbook of experimental pharmacology · doi:10.1007/164_2018_166 · Cited by 103
Geisler, S., Mayersbach, P., Becker, K., Schennach, H., Fuchs, D., & Gostner, J. M. (2015) · Pteridines · doi:10.1515/pterid-2014-0015 · Cited by 95
Self-citationDraper, A., Koch, R. M., van der Meer, J. W., AJ Apps, M., Pickkers, P., Husain, M., & van der Schaaf, M. E. (2018) · Neuropsychopharmacology · doi:10.1038/npp.2017.231 · Cited by 91
Metabolomic/lipidomic profiling of COVID-19 and individual response to tocilizumab
Meoni, G., Ghini, V., Maggi, L., Vignoli, A., Mazzoni, A., Salvati, L., Capone, M., Vanni, A., Tenori, L., Fontanari, P., et al. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009243 · Cited by 99
Immune and Neuroprotective Effects of Physical Activity on the Brain in Depression
Phillips, C., & Fahimi, A. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00498 · Cited by 81
Neurauter, G., Scholl‐Bürgi, S., Haara, A., Geisler, S., Mayersbach, P., Schennach, H., & Fuchs, D. (2013) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2013.10.015 · Cited by 84
Self-citationReininghaus, E. Z., McIntyre, R. S., Reininghaus, B., Geisler, S., Bengesser, S. A., Lackner, N., Hecht, K., Birner, A., Kattnig, F., Unterweger, R., et al. (2014) · Bipolar Disorders · doi:10.1111/bdi.12166 · Cited by 82
Self-citationLevodopa Reverses Cytokine-Induced Reductions in Striatal Dopamine Release
Felger, J. C., Hernandez, C. R., & Miller, A. H. (2015) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyu084 · Cited by 76
Sublette, M. E., & Postolache, T. T. (2012) · Psychosomatic Medicine · doi:10.1097/psy.0b013e318268de9f · Cited by 72
Microglial activation increases cocaine self-administration following adolescent nicotine exposure
Linker, K. E., Gad, M., Tawadrous, P., Cano, M., Green, K. N., Wood, M. A., & Leslie, F. M. (2020) · Nature Communications · doi:10.1038/s41467-019-14173-3 · Cited by 77
Knock-on effect of periodontitis to the pathogenesis of Alzheimer’s disease?
Leblhuber, F., Huemer, J., Steiner, K., Gostner, J. M., & Fuchs, D. (2020) · Wiener klinische Wochenschrift · doi:10.1007/s00508-020-01638-5 · Cited by 77
“Results of the present series confirm that chronic low-grade immune activation and inflammation alter monoamine metabolism that may be involved in the development of neuropsychiatric symptoms characteristic for age and dementia [2, 5, 27, 28].”
BackgroundSelf-citationBeydoun, M. A., Obhi, H. K., Weiss, J., Canas, J. A., Beydoun, H. A., Evans, M. K., & Zonderman, A. B. (2019) · Molecular Psychiatry · doi:10.1038/s41380-019-0408-2 · Cited by 78
Old Friends, immunoregulation, and stress resilience
Langgartner, D., Lowry, C. A., & Reber, S. O. (2018) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-018-2228-7 · Cited by 80
Stapel, B., Sieve, I., Falk, C. S., Bleich, S., Hilfiker‐Kleiner, D., & Kahl, K. G. (2018) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2018.08.017 · Cited by 84
Fatigue in inflammatory rheumatic disorders: pathophysiological mechanisms
Korte, S. M., & Straub, R. H. (2019) · Rheumatology · doi:10.1093/rheumatology/kez413 · Cited by 79
Disturbed Amino Acid Metabolism in HIV: Association with Neuropsychiatric Symptoms
Gostner, J. M., Becker, K., Kurz, K., & Fuchs, D. (2015) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2015.00097 · Cited by 72
Self-citationBiomarkers in Child and Adolescent Depression
Zwolińska, W., Dmitrzak‐Węglarz, M., & Słopień, A. (2021) · Child Psychiatry & Human Development · doi:10.1007/s10578-021-01246-y · Cited by 77
Capuron, L., Geisler, S., Kurz, K., Leblhuber, F., Sperner‐Unterweger, B., & Fuchs, D. (2014) · Current Pharmaceutical Design · doi:10.2174/1381612820666140317110217 · Cited by 73
Self-citationGlial mechanisms underlying substance use disorders
Linker, K. E., Cross, S. J., & Leslie, F. M. (2019) · European Journal of Neuroscience · doi:10.1111/ejn.14163 · Cited by 64
Role of physical activity and diet on mood, behavior, and cognition
Strasser, B., & Fuchs, D. (2015) · Neurology Psychiatry and Brain Research · doi:10.1016/j.npbr.2015.07.002 · Cited by 73
Self-citationElevated Plasma Phenylalanine Predicts Mortality in Critical Patients with Heart Failure
Chen, W., Wang, C., Cheng, C., Liu, M., Chu, C., Wu, H.-P., Huang, P., Lin, Y., Ko, T., Chen, W., et al. (2020) · ESC Heart Failure · doi:10.1002/ehf2.12896 · Cited by 62
Litteljohn, D., Mangano, E. N., Shukla, N., & Hayley, S. P. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.09.025 · Cited by 73
Appetite Regulation of TLR4-Induced Inflammatory Signaling
Li, Y., Jiang, Q., & Wang, L. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.777997 · Cited by 63
Vauzour, D., Martinsen, A., & Layé, S. (2015) · Neurochemistry International · doi:10.1016/j.neuint.2015.08.004 · Cited by 57
Murr, C., Pilz, S., Grammer, T. B., Kleber, M. E., Meinitzer, A., Boehm, B. O., März, W., & Fuchs, D. (2012) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2012-0157 · Cited by 64
Self-citationWissmann, P., Geisler, S., Leblhuber, F., & Fuchs, D. (2013) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2013.03.007 · Cited by 64
Self-citationMood Disorders, Accelerated Aging, and Inflammation: Is the Link Hidden in Telomeres?
Squassina, A., Pisanu, C., & Vanni, R. (2019) · Cells · doi:10.3390/cells8010052 · Cited by 55
Xu, J., Pan, T., Qi, X., Tan, R., Wang, X., Liu, Z., Tao, Z., Qu, H., Zhang, Y., Chen, H., et al. (2020) · Respiratory Research · doi:10.1186/s12931-020-01364-6 · Cited by 60
Ellul, P., Mariotti‐Ferrandiz, E., Leboyer, M., & Klatzmann, D. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00167 · Cited by 59
Hyperproliferation is the main driver of metabolomic changes in psoriasis lesional skin
Pohla, L., Ottas, A., Kaldvee, B., Abram, K., Soomets, U., Zilmer, M., Reemann, P., Jaks, V., & Kingo, K. (2020) · Scientific Reports · doi:10.1038/s41598-020-59996-z · Cited by 60
Petruso, F., Giff, A., Milano, B. A., Rossi, M. M. D., & Saccaro, L. F. (2023) · Neuronal Signaling · doi:10.1042/ns20220077 · Cited by 60
The metabolomics of psoriatic disease
Yan, D., Afifi, L., Jeon, C., Trivedi, M. K., Chang, H. W., Lee, K. M., & Liao, W. J. (2017) · Psoriasis Targets and Therapy · doi:10.2147/ptt.s118348 · Cited by 57
Marcos-Pérez, D., Sánchez-Flores, M., Maseda, A., Lorenzo‐López, L., Millán-Calentí, J. C., Strasser, B., Gostner, J. M., Fuchs, D., Pásaro, E., Valdiglesias, V., et al. (2017) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2017.06.021 · Cited by 53
Self-citationSaggu, S., Pless, A., Dew, E., Ware, D., Jiao, K., & Wang, Q. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1543730 · Cited by 52
Sipahi, H., Mat, A. F., Özhan, Y., & Aydın, A. (2022) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026623666221223111309 · Cited by 53
Toxoplasma gondii, Suicidal Behavior, and Intermediate Phenotypes for Suicidal Behavior
Postolache, T. T., Wadhawan, A., Rujescu, D., Hoisington, A. J., Dagdag, A., Baca‐García, E., Lowry, C. A., Okusaga, O. O., & Brenner, L. A. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.665682 · Cited by 51
Fatigue in Patients with Lung Cancer Is Related with Accelerated Tryptophan Breakdown
Kurz, K., Fiegl, M., Holzner, B., Giesinger, J., Pircher, M., Weiss, G., Denz, H. A., & Fuchs, D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036956 · Cited by 45
Self-citationToxoplasma gondii: A possible etiologic agent for Alzheimer's disease
Nayeri, T., Sarvi, S., Sharif, M., & Daryani, A. (2021) · Heliyon · doi:10.1016/j.heliyon.2021.e07151 · Cited by 47
Three aromatic amino acids in gastric juice as potential biomarkers for gastric malignancies
Deng, K., Lin, S., Zhou, L., Geng, Q., Li, Y., Xu, M. G., & Na, R. (2011) · Analytica Chimica Acta · doi:10.1016/j.aca.2011.03.053 · Cited by 46
Immune activation and inflammation increase the plasma phenylalanine-to-tyrosine ratio
Geisler, S., Gostner, J. M., Becker, K., Ueberall, F., & Fuchs, D. (2013) · Pteridines · doi:10.1515/pterid-2013-0001 · Cited by 46
Self-citationIntegrating the monoamine and cytokine hypotheses of depression: Is histamine the missing link?
Hersey, M., Hashemi, P., & Reagan, L. P. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.15392 · Cited by 46
Ormstad, H., Verkerk, R. M., & Sandvik, L. (2015) · Journal of Molecular Neuroscience · doi:10.1007/s12031-015-0659-6 · Cited by 45
Naemat, A., Elsheikha, H. M., Boitor, R., & Notingher, I. (2016) · Scientific Reports · doi:10.1038/srep20811 · Cited by 42
Picker, L. D., Fransén, E., Coppens, V., Timmers, M., de Boer, P., Oberacher, H., Fuchs, D., Verkerk, R. M., Sabbe, B., & Morrens, M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02971 · Cited by 42
Self-citationChen, S., Zhang, C., Xiong, Y., Tian, X., Liu, C., Elango, J., & Wu, W. (2015) · Innovative Food Science & Emerging Technologies · doi:10.1016/j.ifset.2015.07.003 · Cited by 39
Markers of Inflammation and Monoamine Metabolism Indicate Accelerated Aging in Bipolar Disorder
van den Ameele, S., Fuchs, D., Coppens, V., de Boer, P., Timmers, M., Sabbe, B., & Morrens, M. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00250 · Cited by 43
Self-citationLu, X., Qi, C., Jin, L. G., Zheng, J., Sun, M., Tang, X., Li, D., & Sun, J. (2021) · Food & Function · doi:10.1039/d0fo01978j · Cited by 40
Korte-Bouws, G. A. H., Albers, E., Voskamp, M. J., Hendriksen, H., de Leeuw, L. R., Güntürkün, O., de Roock, S., Vastert, S. J., & Korte, S. M. (2019) · Pharmaceuticals · doi:10.3390/ph12010009 · Cited by 40
Metadata
- Authors
- Neurauter, G., Schrocksnadel, K., Scholl-Burgi, S., Sperner-Unterweger, B., Schubert, C., Ledochowski, M., & Fuchs, D.
- Affiliations
- Innsbruck Medical University (AT)
- Corresponding author
- Schubert, C.
- Fuchs, D.
- Venue
- Current Drug Metabolism
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2008-09-01
- Volume
- 9
- Issue
- 7
- Pages
- 622-627
- ISSN
- 1389-2002 (ISSN-L)
- OpenAlex
- W2098108268
- Cited by
- 274
- References
- 0
- Citations by year
- 2026: 7 · 2025: 13 · 2024: 14 · 2023: 18 · 2022: 24 · 2021: 28 · 2020: 27 · 2019: 23 · 2018: 19 · 2017: 17 · 2016: 16 · 2015: 16 · 2014: 8 · 2013: 15 · 2012: 12
- FWCI
- 1.89
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Current Drug Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
- Keywords
- chronic immune stimulation, interferon-gamma, tetrahydrobiopterin, catecholamine synthesis, serotonin synthesis, neuropsychiatric symptoms, depression, autoimmune disease, chronic inflammation, reactive oxygen species
- MeSH terms
- Animals, Biopterins, Homocysteine, Humans, Immune System, Inflammation, Interferon-gamma, Phenylalanine, Biogenic Monoamines, Oxidative Stress
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.